Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients

scientific article published on 19 February 2018

Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1101105789
P356DOI10.1007/S11060-018-2803-Y
P698PubMed publication ID29460097

P50authorAdomas BuneviciusQ43239704
P2093author name stringGiorgio Iervasi
Robertas Bunevicius
Arimantas Tamasauskas
Sarunas Tamasauskas
Vytenis Deltuva
Andrius Radziunas
Edwards R Laws
P2860cites workSecretion of interleukin-6 by human meningioma cells: possible autocrine inhibitory regulation of neoplastic cell growthQ72121877
Effect of interleukin-1 and dexamethasone on interleukin-6 production and growth in human meningiomasQ74295906
CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events?Q79399756
Peritumoral edema and prognosis in intracranial meningioma surgeryQ31152316
Independent association of extent of resection with survival in patients with malignant brain astrocytomaQ33375165
Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growthQ33674790
Assessment of outcome after severe brain damageQ34216702
Serum hsCRP: A Novel Marker for Prediction of Cerebrovascular Accidents (Stroke).Q35046289
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisQ35182277
Association of C-reactive protein with cognitive impairmentQ35591752
Impaired survival and long-term neurological problems in benign meningiomaQ35914505
Role of IL-6 in the invasiveness and prognosis of gliomaQ35958905
Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysisQ36134214
Peripheral Inflammatory Markers and Antioxidant Response during the Post-Acute and Chronic Phase after Severe Traumatic Brain InjuryQ37385572
The pro- and anti-inflammatory properties of the cytokine interleukin-6.Q37836084
Pathophysiological mechanisms regulated by cytokines in gliomasQ38280199
Resection of olfactory groove meningioma - a review of complications and prognostic factors.Q38547145
Immune microenvironment of gliomasQ38712457
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillationQ38930939
Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma?Q39976588
Prognostic and clinical implication of IL-6 expression in glioblastoma multiformeQ40344057
Clinical prognostic factors in adults with astrocytoma: Historic cohortQ40743051
Early Dynamics of P-selectin and Interleukin 6 Predicts Outcomes in Ischemic StrokeQ40861162
Association of pre-operative depressive and anxiety symptoms with five-year survival of glioma and meningioma patients: a prospective cohort studyQ41340729
Interleukin-6 gene amplification and shortened survival in glioblastoma patients.Q42549981
Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with gliomaQ43715694
Increased C-reactive protein implies a poorer stage-specific prognosis in colon cancerQ43897776
Elevated serum IL-17A but not IL-6 in glioma versus meningioma and schwannomaQ44573064
Influence of interleukin-6 on the development of peritumoral brain edema in meningiomasQ47792323
Low triiodothyronine syndrome as a predictor of poor outcomes in patients undergoing brain tumor surgery: a pilot study: clinical articleQ48130916
Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastomaQ48137961
Role of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and inteleukin-6 in predicting a poor outcome after a strokeQ48181059
APRIL is increased in serum of patients with brain glioblastoma multiforme.Q48246760
Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients.Q48548524
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013.Q52096226
Prognostic importance of markers for inflammation, angiogenesis and apoptosis in high grade glial tumors during temozolomide and radiotherapy.Q53265090
Similar immunity profiles in patients with meningioma and glioma tumors despite differences in the apoptosis and necrosis of circulating lymphocyte and monocyte populations.Q55461101
The acute phase responseQ71618259
P577publication date2018-02-19
P1433published inJournal of Neuro-OncologyQ15752119
P1476titlePrognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients